ISET 2022: AAA-SHAPE Study Shows No Adverse Events with IMPEDE-FX Plug | Dr Andrew Holden

Подробнее о видео

Watch the full video on Radcliffe Vascular here:

In this video from ISET 2022, Dr Andrew Holden (Auckland City Hospital, Auckland, NZ) outlines the findings of the AAA-Shape study, a prospective single-center safety study designed to investigate the safety and efficacy of the IMPEDE-FX Embolization Plug. Outcomes show that out of 16 EVAR patients treated with the embolization plug, there was a 100% rate of technical success, with no adverse events, no endoleaks and significant sac shrinkage.

Discussion Points:
1. Study Purpose
2. IMPEDE-FX Technology
3. Key Findings
4. Take-Home Messages
5. Further Research

Recorded remotely from Auckland, 2022.
Interviewer: Jordan Rance

This content is intended for healthcare professionals only.

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.